AWS
INFI

Atria Wealth Solutions’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Atria Wealth Solutions’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,000
Closed -$1.6K – 2014
2023
Q1 		$1.6K Hold
10,000
– – ﹤0.01% 1852
2022
Q4 		$5.55K Sell
10,000
-10,000
-50% -$8.51K ﹤0.01% 1793
2022
Q3 		$23.8K Hold
20,000
– – ﹤0.01% 1727
2022
Q2 		$13K Buy
+20,000
New +$15.4K ﹤0.01% 1617

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Atria Wealth Solutions's INFI Position: Q2 2023 in Review

Atria Wealth Solutions sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2023, closing a stake of 10,000 shares — an estimated $1.6K sold.

Atria Wealth Solutions first reported a position in INFI in Q2 2022 and held it in 4 quarters. The position peaked at $23.8K in Q3 2022. 45 funds tracked by Wall St. Rank hold INFI as of Q2 2023.

  • Atria Wealth Solutions reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Atria Wealth Solutions sold 10,000 Infinity Pharmaceuticals, Inc. shares in Q2 2023, an estimated $1.6K.
  • Atria Wealth Solutions first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2022 and held it in 4 quarters.
  • Atria Wealth Solutions's Infinity Pharmaceuticals, Inc. position peaked at $23.8K in Q3 2022.
  • 45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2023.

Based on Atria Wealth Solutions's 13F filing for Q2 2023, filed 3 Aug 2023.